Editor’s Note:If you or someone you know is struggling with suicidal thoughts or mental health matters, please call the 988 Suicide & Crisis Lifeline by dialing 988 to connect with a trained counselor, or visit the 988 Lifeline website.
People taking semaglutide, the popular medication for diabetes and weight loss, are more likely to report having thoughts of suicide compared with those taking other drugs, according to a new study of an international drug safety database. But the finding is the latest see-saw of scientific evidence on the risk of depression and suicide tied to the popular medications — and critics say evidence that the drugs cause problems with mood is limited.
I am an epidemiologist, currently funded by GlaxoSmithKline. I initially studied physiology at BSc and PhD level in Manchester. Since then, I spent several years at the UK Medicines & Healthcare Products Regulatory Agency and in the pharmaceutical industry investigating adverse effects of drugs – both in clinical trials and post-marketing. I completed the MSc in epidemiology at LSHTM in 2005.
In 2015, six psychiatrists from the Department of Psychiatry, University of Oxford, the UK, published the study, “Depression and Violence: A Swedish Population Study” in Lancet Psychiatry.
Late last year, the U.S. Food and Drug Administration (FDA) quietly introduced a regulation that may be one of the most important shifts in how non-profit and for-profit U.S. institutions, both at home and abroad, conduct future medical and public health research. It represents an erosion of personal medical choice and threatens to undermine the public’s trust in scientific investigations in biomedicine.
Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.
You may already know that magnesium is one of the top supplements for healthy aging, but its benefits go beyond supporting you in your golden years. “It’s essential for all stages of life,” says Andrea Wong, Ph.D., senior vice president for scientific and regulatory affairs at the Council for Responsible Nutrition (CRN).
420 FILE – The United States government is likely to end the designation of marijuana as a dangerous narcotic sometime this year, potentially marking one of the biggest federal decisions on the classification of the drug in decades. The U.S. Food and Drug Administration determined that marijuana is less harmful than, say, opioids and other substances, prompting the Biden administration to announce it would “reschedule” cannabis from a Schedule I—which is what the most dangerous drugs are classified as—to a Schedule III drug, commensurate with anabolic steroids and ketamine.
FYI, I’m not against cannabis for medicinal purposes. Especially since I can’t even get a prescription for any painkillers. I could rant about it, but I won’t.
The FDA has agreed to delete and never republish several social-media posts suggesting that ivermectin, a drug that some doctors used to treat COVID-19, is for animals and not humans.
While the FDA still does not approve of using ivermectin to treat COVID, it settled Thursday a lawsuit brought by three doctors who sued it, as well as the Department of Health and Human Services and its secretary, Xavier Becerra, and FDA secretary Robert Califf. All parties have settled.
…
At its website as of Friday, the FDA still is not recommending it for COVID and says large doses are dangerous and that prescriptions should be filled by a pharmacy and taken exactly as prescribed.
The FDA declined to respond to Kennedy’s assertion, though it reiterated that it “has not changed its position that currently available clinical trial data do not demonstrate that ivermectin is effective against COVID-19. The agency has not authorized or approved ivermectin for use in preventing or treating COVID-19.”
I honestly don’t know what difference this’ll make. 🤷🏼♀️
A group of 400 Israeli survivors of the October 7 Hamas attack, including civilians, released hostages, and soldiers, could be offered MDMA-assisted psychotherapy in a potentially trailblazing study to commence later this year.
…
“Our goal is to create a therapy model that can serve universally, with the intention and prayer to help people,” said Dr. Keren Tzarfaty, CEO and co-founder of MAPS Israel, which is already running trials evaluating MDMA-assisted therapy for the treatment of post-traumatic stress disorder, depression, and eating disorders. “We hope it will demonstrate high levels of safety and effectiveness and enable us to offer the program in other places over the region and the world, not only to treat PTSD, but to help people open their hearts and expand their minds.”
…
Dr. Rick Doblin, founding president of the U.S.-based MAPS and a longtime advocate for using psychedelic therapy in the Israeli–Palestinian conflict, said that the study would serve as a seminal piece of research into whether psychedelic-assisted therapy can help large groups of traumatized people.
“. . . if the major media picks up on this story, they will have the chance to report on what arguably is the worst—and most harmful—scandal in American medical history”
Historically, there have always been some patients who report that any treatment for depression—including bloodletting—has worked for them, but science demands that for a treatment to be deemed truly effective, it must work better than a placebo or the passage of time without any treatment. This is especially important for antidepressant drugs—including Prozac, Zoloft, and other selective serotonin reuptake inhibitors (SSRIs), as well as Effexor, Cymbalta, and other serotonin and norepinephrine reuptake inhibitors (SNRIs)—because all of these drugs have uncontroversial troubling side effects.
Ms. Cat’s Chronicles 
You must be logged in to post a comment.